StockNews.com upgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a hold rating to a buy rating in a research note ...
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback